# Theraclion: Form D filing

Theraclion, a biotechnology company in Malakoff, France, filed a Form D with the SEC in 2015. The latest, on July 1, 2015, reports $250,000 sold of a $250,000 offering to 1 investor.

Find out what Theraclion does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Theraclion%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Theraclion&page=%2Fdata%2Fform-d%2Fcompany%2Ftheraclion-1646900)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Theraclion%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Theraclion&page=%2Fdata%2Fform-d%2Fcompany%2Ftheraclion-1646900)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 102, RUE ETIENNE DOLET, Malakoff, France, 92240
- Phone: 011 33 1 5548 9070
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: France
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1646900

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 1, 2015 | New notice | $250,000 | $250,000 | $0 | 1 | Jun 19, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1646900/000164690015000001/0001646900-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michel Nuta | Executive Officer |  |
| Bern Von Polheim | Director |  |
| Sarah Ankri | Executive Officer |  |
| Laurent Levy | Director |  |
| Sylvain Yon | Executive Officer |  |
| Francois LaCoste | Director |  |
| Anja Kleber | Executive Officer |  |
| Jean-Yves Burel | Director |  |
| David Caumartin | Executive Officer |  |
| Phillippe Pouletty | Director |  |
| Vincent Gardes | Director |  |

[Every Form D from the week of Jun 29, 2015](https://specstream.ai/data/form-d/week/2015-06-29) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Theraclion reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).
